Juris J Meier Selected Research

Canagliflozin

1/2019

Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Juris J Meier Research Topics

Disease

73	Type 2 Diabetes Mellitus (MODY) 11/2022 - 07/2002
13	Body Weight (Weight, Body) 01/2022 - 04/2002
13	Hypoglycemia (Reactive Hypoglycemia) 01/2021 - 03/2004
9	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 11/2021 - 08/2006
7	Hyperglycemia 01/2021 - 12/2004
7	Weight Loss (Weight Reduction) 01/2021 - 09/2003
6	Obesity 01/2022 - 04/2002
6	Heart Failure 01/2022 - 12/2012
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020 - 05/2009
6	Pancreatitis 01/2020 - 08/2006
6	Critical Illness (Critically Ill) 01/2015 - 03/2004
5	Neoplasms (Cancer) 01/2020 - 11/2002
5	Chronic Pancreatitis 01/2020 - 05/2009
5	Glucose Intolerance 06/2015 - 06/2006
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2019
4	Diabetes Mellitus 04/2021 - 09/2015
4	Myocardial Infarction 01/2021 - 10/2005
3	Weight Gain 01/2020 - 04/2002
3	Nausea 01/2020 - 06/2005
3	Vomiting 01/2020 - 06/2005
3	Non-alcoholic Fatty Liver Disease 08/2015 - 10/2007
3	Insulin Resistance 05/2012 - 02/2010
3	Colonic Neoplasms (Colon Cancer) 12/2010 - 01/2003
3	Colorectal Neoplasms (Colorectal Cancer) 12/2010 - 07/2003
2	Gastroesophageal Reflux (GERD) 01/2022 - 01/2020
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2021 - 08/2015
2	Inflammation (Inflammations) 08/2017 - 03/2004
2	Acute Coronary Syndrome 08/2017 - 07/2002
2	Hyperplasia 11/2016 - 07/2006
2	Insulinoma 05/2016 - 12/2012
2	Infections 09/2011 - 11/2002
2	Adenoma (Adenomas) 07/2009 - 01/2003
2	Morbid Obesity 10/2008 - 07/2006
2	Adenocarcinoma 01/2003 - 11/2002
1	Kidney Diseases (Kidney Disease) 01/2022
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 01/2022
1	Gastritis 01/2022
1	Vascular Diseases (Vascular Disease) 01/2021
1	Stroke (Strokes) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	COVID-19 12/2020
1	Amyloid Plaque 01/2020
1	Heart Diseases (Heart Disease) 12/2019
1	Endocrine System Diseases (Endocrine Diseases) 12/2019

Drug/Important Bio-Agent (IBA)

56	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 06/2003
42	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 04/2002
37	Insulin (Novolin)FDA Link 03/2022 - 05/2003
23	IncretinsIBA 01/2022 - 03/2004
14	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2022 - 12/2012
12	Hormones (Hormone)IBA 01/2022 - 03/2004
12	Glucagon (Glukagon)FDA Link 01/2022 - 04/2006
10	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2022 - 01/2003
9	Liraglutide FDA Link 01/2021 - 06/2005
8	lixisenatideIBA 01/2022 - 07/2015
8	semaglutideIBA 01/2022 - 08/2017
7	Peptides (Polypeptides)IBA 01/2022 - 12/2004
7	Hypoglycemic Agents (Hypoglycemics)IBA 01/2021 - 04/2011
7	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 09/2011
6	Insulin Glargine (Lantus)FDA Link 01/2022 - 09/2011
6	C-PeptideIBA 12/2012 - 05/2003
5	Exenatide (Byetta)FDA Link 01/2021 - 06/2005
5	Blood Glucose (Blood Sugar)IBA 06/2015 - 03/2004
4	SodiumIBA 01/2022 - 01/2019
4	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2020 - 04/2015
4	Glucagon-Like Peptide-1 ReceptorIBA 12/2019 - 01/2017
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010 - 05/2003
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2021 - 08/2017
3	empagliflozinIBA 01/2021 - 02/2017
3	Pharmaceutical PreparationsIBA 04/2015 - 01/2006
2	AcidsIBA 11/2022 - 01/2020
2	LinagliptinIBA 01/2022 - 02/2017
2	octanoic acid (caprylic acid)IBA 01/2021 - 06/2003
2	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2021 - 03/2004
2	Amyloid (Amyloid Fibrils)IBA 01/2020 - 12/2006
2	Glucagon-Like Peptides (Enteroglucagon)IBA 01/2020 - 01/2006
2	dapagliflozinIBA 01/2019 - 09/2011
2	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 08/2015 - 03/2004
2	ThiazolidinedionesIBA 04/2013 - 12/2012
2	ProinsulinIBA 12/2012 - 10/2010
2	Amino Acids FDA Link 02/2010 - 05/2009
2	Proteins (Proteins, Gene)FDA Link 05/2009 - 01/2003
2	NF-kappa B (NF-kB)IBA 01/2004 - 01/2003
2	Messenger RNA (mRNA)IBA 07/2003 - 05/2003
1	Proglucagon (Glucagon Precursors)IBA 01/2022
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2022
1	cotadutideIBA 01/2020
1	Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA 01/2020
1	rGLP-1 proteinIBA 12/2019
1	dulaglutideIBA 12/2019
1	CanagliflozinIBA 01/2019

Therapy/Procedure

15	Therapeutics 01/2022 - 09/2011
4	Drug Therapy (Chemotherapy) 01/2022 - 04/2002
4	Glycemic Control 01/2021 - 09/2011
3	Injections 01/2021 - 06/2005
3	Intravenous Infusions 06/2015 - 12/2003
3	Pancreatectomy 08/2009 - 07/2006
2	Aftercare (After-Treatment) 01/2022 - 10/2021
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 01/2018 - 07/2006
2	Bariatric Surgery 01/2018 - 01/2016
2	Islets of Langerhans Transplantation 01/2007 - 08/2006